Luminor Medical Technologies is a medical diagnostic company, focuses on acquiring, developing, and commercializing non-invasive tests for unmet clinical needs in Canada. The company’s products and services include PREVU Skin Cholesterol Test, a non-invasive test that measures cholesterol in the skin tissues to assess risk of coronary artery disease or heart disease; PSP94, an enzyme linked immunosorbent assay for urine specimens; and testing services. Its diagnostic programs under development comprise cardiovascular disease, preeclampsia, prostate cancer, colorectal cancer, pancreatic cancer, and gastric cancer programs. The company has a partnership agreement with Alere, Inc. for the development of tests for preeclampsia biomarkers.
VeraLight is a medical device company that was established in October 2004 to focus on a comprehensive approach to non-invasive type 2 diabetes and pre-diabetes screening with the proprietary SCOUT DS® system. Their mission is to help stem the tide of the worldwide diabetes epidemic by driving early diabetes detection, thus enabling initiation of therapies that can prevent diabetes or reduce its complications. The company develops and acquires intellectual property, products, and services that contribute to this mission.
Europroteome AG
Acquisition in 2005
Europroteome AG develops diagnostic, immunological, and prognostic tools as well as patient-specific therapies for human epithelial cancers.